Reuters -- U.S. health officials are looking into whether patients with a certain bone marrow disorder are more at risk for death and serious complications with Novartis AG’s drug Exjade.
Reuters -- U.S. health officials are looking into whether patients with a certain bone marrow disorder are more at risk for death and serious complications with Novartis AG’s drug Exjade.
